Details of the Drug

General Information of Drug (ID: DMHJXEE)

Drug Name
PF-3635659
Synonyms PF-03635659
Indication
Disease Entry ICD 11 Status REF
Chronic obstructive pulmonary disease CA22 Phase 2 [1]
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL
Chemical Identifiers
Formula
C28H32N2O3
Canonical SMILES
CC(C)(CCC(C1=CC=CC=C1)(C2=CC=CC=C2)C(=O)N)N3CC(C3)OC4=CC=CC(=C4)O
InChI
InChI=1S/C28H32N2O3/c1-27(2,30-19-25(20-30)33-24-15-9-14-23(31)18-24)16-17-28(26(29)32,21-10-5-3-6-11-21)22-12-7-4-8-13-22/h3-15,18,25,31H,16-17,19-20H2,1-2H3,(H2,29,32)
InChIKey
WGOJWDWKHJHXSV-UHFFFAOYSA-N
Cross-matching ID
PubChem CID
16065403
ChEBI ID
CHEMBL1910856
CAS Number
931409-24-4
UNII
O0RG3QM34H
DrugBank ID
DB12408
TTD ID
D0I5XU
Drug-Molecule Activity Atlas (DMA)NEW Click to Jump to the Detailed DMA Information of This Drug
Drug ADMET Endpoint Profile (DAE)NEW Click to Jump to the Detailed DAE Information of This Drug

References

1 ClinicalTrials.gov (NCT01033487) A Study To Examine The Safety, Pharmacokinetics And Pharmacodynamics Of PF-03635659 In Patients With Chronic Obstructive Pulmonary Disease. U.S. National Institutes of Health.